Results 61 to 70 of about 2,218 (130)
Malabsorption of Flucytosine in a Pediatric Patient with Shwachman Syndrome
, 1989 The malabsorption of drugs from the gastrointestinal tract in patients with pancreatic insufficiency is not well documented in the literature. We describe a case of flucytosine malabsorption in a pediatric patient with Shwachman syndrome, a rare disease
Karen J. Harper, William T. Sawyer
core +1 more source
Transplant Infectious Disease, Volume 28, Issue 4, July/August 2026.Among 346 liver transplant recipients, rural residence conferred a 3.3‐fold higher risk of cryptococcal infection — a novel finding suggesting environmental exposure or healthcare access barriers may drive susceptibility. Triple immunosuppression and longer waitlist duration were additional risk factors, with very early infection carrying the worst ...
Rachel Sigler +11 more
wiley +1 more source
, 2003 Two patients with renal failure and fluconazole resistant but flucytosine susceptible Candida deep infection were successfully treated with the combination of the two drugs.
VENDITTI, Mario +2 more
core +1 more source
, 2007 International audienceInactivation of the FCY2 (cytosine permease), FCY1 (cytosine deaminase), and FUR1 (uracil phosphoribosyltransferase) genes in Candida lusitaniae produced two patterns of resistance to flucytosine. Mutant fur1 demonstrated resistance
Florent, Martine +7 more
core +1 more source
Pathogens(1) Background: Meyerozyma guilliermondii is a yeast species widely distributed in the natural environment and one of the rare emerging pathogens capable of causing difficult to treat, severe infections.
Aleksandra Górzyńska +5 more
doaj +1 more source
Journal of Clinical Laboratory Analysis, Volume 40, Issue 11, June 2026.Naganishia diffluens, a rare non‐neoformans cryptococcal species, was identified by PCR sequencing as the causative agent of oral cryptococcosis in a 31‐year‐old Iranian man with β‐thalassemia. This case represents the first documented instance of oral infection by N.
Zahra Yahyazadeh +13 more
wiley +1 more source
, 2005 Flucytosine (5-fluorocytosine) is the fluorine analogue of the naturally occurring nucleic acid pyrimidine base, cytosine. Flucytosine inhibits deoxyribonucleic acid (DNA) synthesis within fungi by acting as a noncompetitive inhibitor of thymidylate ...
Joel M. Weinstein, MD
core
Flucytosine and cryptococcosis : which in vitro test is the best predictor of outcome?
, 2003 The combination of flucytosine and amphotericin B is first choice treatment for active cryptococcosis. Because of innate or acquired resistance of Cryptococcus neoformans to flucytosine, in vitro testing is mandatory.
A.M. Tortorano +3 more
core +1 more source
The Effect of Cilofungin (LY 121019) in Combination with Amphotericin B or Flucytosine Against Candida Species [PDF]
, 1989 Cilofungin was combined with amphotericin B or flucytosine to determine if synergistic inhibition or killing occurred against 50 strains of various Candida species.
Bradley, Suzanne F. +5 more
core +1 more source
Diversity in Translation: Equal Is Greater Than
Clinical and Translational Science, Volume 19, Issue 9, September 2026.
Elvin T. Price, John A. Wagner
wiley +1 more source